Breast cancer research topics. Cancer Research 2022-10-30
Breast cancer research topics Rating:
6,4/10
975
reviews
Breast cancer is a major health concern for women around the world, with millions of cases diagnosed each year. Research into this disease has led to many important advances in treatment, such as the development of targeted therapies that are more effective and have fewer side effects than traditional chemotherapy. However, there is still much that scientists do not understand about breast cancer, and there are many topics that are ripe for research. Here are a few examples:
Risk factors for breast cancer: There are many known risk factors for breast cancer, such as genetics, age, and lifestyle factors like alcohol consumption and lack of physical activity. However, researchers are still working to understand the complex interplay between these factors and how they contribute to the development of the disease. Further research in this area could lead to better strategies for preventing breast cancer or identifying it early on.
Genetic factors in breast cancer: Scientists have identified many genetic mutations that are associated with an increased risk of breast cancer, and they are working to understand how these mutations contribute to the development of the disease. This research could lead to personalized treatments that are tailored to the specific genetic profile of a patient's cancer.
Metastasis: Breast cancer is often deadly because it spreads, or metastasizes, to other parts of the body. Researchers are working to understand the process of metastasis and how to prevent or treat it. This could involve targeting specific molecules that drive the spread of cancer cells or developing drugs that help to block metastasis.
Immunotherapy: Another area of active research is the use of the immune system to fight breast cancer. This could involve developing therapies that stimulate the immune system to attack cancer cells or blocking pathways that allow cancer cells to evade the immune system.
Quality of life for breast cancer survivors: Breast cancer treatment can be grueling and can have long-term effects on a person's physical and mental health. Researchers are working to understand these effects and to develop interventions to improve the quality of life for breast cancer survivors.
These are just a few examples of the many research topics that are currently being studied in the field of breast cancer. As scientists continue to make progress, we can hope for even more effective treatments and strategies for combating this disease.
What’s New in Breast Cancer Research?
Epub 2019 May 17. In addition to basic research, the journal publishes preclinical, translational and clinical studies with a biological basis, including Phase I and Phase II trials. Greene LR, Wilkinson D. Cancer is a disease caused by abnormal uncontrolled cell growth in the body. Advances in the diagnosis and adjuvant treatment of breast cancer have led to improved outcomes, with the large majority of women who have operable cancer today expected to be alive and recurrence-free in 5 years. Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis. Bernard, in Genomic and Personalized Medicine Second Edition , 2013 Introduction Breast cancer is the most prevalent cancer in the world ~4.
A digital journal for innovative original research and fresh, bold ideas in clinical trial design and clinical decision-making. Peer-reviewed journal featuring in-depth articles to accelerate the transformation of health care delivery. Incidence rates have increased slightly—by about 0. This chapter does not provide guidelines for the botanical treatment of breast cancer, although does direct readers to additional resources on evidence for botanicals commonly used in cancer treatment protocol. A Vaccine Alpha-Lactalbumin for the Treatment of Stage II-III Triple-Negative Breast Cancer. Accessed August 15, 2019. Published 2021 Jul 29.
85 Breast Cancer Topic Ideas to Write about & Essay Samples
Event-free survival at 3 years was 84. Each format of essay has its own beauty and one must know how to observe that beauty and come up with a great description. Intraductal epithelial cells account for the vast majority of breast cancer Russo et al. Radiation therapy, if indicated, is typically offered after chemotherapy. Clinical application of circulating tumor DNA in breast cancer.
15 Good Argumentative Essay Topics About Breast Cancer
Ruxolitinib in Preventing Breast Cancer in Patients with High Risk and Precancerous Breast Lesions. Raymond Reilly, in xPharm: The Comprehensive Pharmacology Reference, 2007 Definition Breast cancer is an uncontrolled growth of epithelial cells originating in the ducts or breast lobules Carbone et al 1993. Breast Cancer Research is an international, peer-reviewed online journal, publishing original research, reviews, editorials and reports. Our understanding of the possible etiological factors has been obtained by considering information derived from epidemiological studies, including genetic epidemiology studies and information derived over 7 decades on the basic physiology, anatomy, and cellular signaling within the cellular matrix of breast tissue. A 65-year-old man presented with a 7-month history of painless skin thickening over the left side of his chest and on his left arm. Litton JK, Burstein HJ, Turner NC. The process is led by These publications provide detailed analyses and estimates of breast cancer incidence and mortality trends in the United States.
Useful Tips and Topics for Literature Review on Breast Cancer
It is hoped that this chapter will help the reader begin to understand the magnitude of breast cancer as a disease that effects all women, whether as a direct clinical reality or a lifelong concern, to understand nonmodifiable and modifiable breast cancer risk factors, to gain perspective on the complexity of issues women must sort through regarding screening and, if diagnosed, choices regarding their treatment, including whether and how to use CAM therapies. An interim analysis of a randomized trial in triple-negative breast cancer comparing the addition of pembrolizumab to neoadjuvant chemotherapy with chemotherapy alone and adjuvant pembrolizumab with placebo after definitive surgery was reported after 39 months of follow-up. Breast cancer is one of the most concerning diseases in the world. J Cancer Res Clin Oncol. This is equivalent to a breast cancer diagnosis every 2 minutes.
Physiological studies in animals and humans have provided a valuable framework in which to consider the etiology of breast cancer by describing the growth, differentiation, and involution of breast tissue at menopause and the critical role of the breast ductal cell microenvironment. . Adjuvant endocrine therapy is associated with an approximate 50% reduction in breast cancer recurrence. However, the bulk of this risk is skewed toward the sixth decade and beyond with age the main risk factor for the development of breast cancer. No between-group differences were noted in disease-free survival, but patients in the 5-year group had more bone. While this study helps us better understand the role body weight before a diagnosis has on survival after a diagnosis of breast cancer, it is difficult to disentangle the multifactorial role of body weight.
Before taking the topic to your supervisor, make sure that it is supported by articles that have been published in authentic journals. Shoukry M, Broccard S, Kaplan J, Gabriel E. Chemotherapy is considered for those at high risk for recurrence, characterized by large tumor size, positive lymph nodes, high-grade histology, or a triple negative hormone receptor—negative, HER2-negative breast cancer. Some of these are already being used in certain situations, while others are still being studied. For women, the death rate declined 43% between 1989 and 2020. There is controversy over screening methods, treatments, and the role of complementary and alternative therapies in the care of women with breast cancer. Am Fam Phys 49 2 :445-450, 1994.
Gene—nutrient interaction plays a key role in breast cancer, and the factors that influence susceptibility to breast cancer from an environmental and genetic standpoint remain poorly understood. We regret any print delays and are working to ensure all issues are delivered as soon as possible. Breast cancer prevention Researchers are looking for ways to help reduce breast cancer risk, especially for women who are at high risk. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. In patients with HER2 expressing breast cancers, standard adjuvant regimens also include the addition of trastuzumab and pertuzumab for 1-yr duration.
Breast Cancer articles: The New England Journal of Medicine
The disease is differentiated from benign breast pathologies, such as fibroadenoma, fibrocystic disease, or benign hyperplasia. However, women with hormone-receptor—positive breast cancer remain at constant annual risk of recurrence for at. Thank you for your patience. Clinical trials are carefully controlled studies that can gather specific information about certain diseases as well as explore promising new treatments. In Dizon DS, Pennel N, Rugo HS, Pickell LF, eds. Although there are awareness campaigns and sessions organized all over the world, this subject still needs further research and study to minimize, if not eliminate, the number of affecters. Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer.
Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility. Testing the Addition of a Blood Pressure Medication, Carvedilol, to HER-2 Targeted Therapy for Metastatic Breast Cancer to Prevent Cardiac Toxicity. Ignatiadis M, Lee M, and Jeffrey SS. A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. She was diagnosed with a rare cancer, and her mother was diagnosed with inflammatory breast cancer IBC even though none of the known risk factors applied to her. In the setting of operable breast cancer, neoadjuvant systemic treatment may be recommended to optimize surgical outcomes in the setting of a large tumor or to allow for breast-conserving surgery.
